ISRCTN98642570Recruiting未知
Surveillance of Tolerability And Treatment Efficacy of Wilate® in von Willebrand?s disease: an observational study
Octapharma GmbH (Germany)0 sites120 target enrollmentStarted: December 5, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. The patient suffers from hereditary or acquired von Willebrand's disease and is in need for replacement of coagulation concentrate containing von Willebrand factor (VWF)
- •2. When bleeding history is positive, other causes were excluded
Exclusion Criteria
- •1. The patient could actually be treated with DDAVP (Desmopressin Acetate)
- •2. The patient has a von Willebrand factor activity over 70 % and there are no findings manifesting the von Willebrand (VWD) diagnosis like
- •2.1. Bleeding pattern compliant with VWD
- •2.2. Positive family history
- •2.3. Mutation analysis
- •2.4. Multimer pattern
Investigators
Similar Trials
Completed
Not Applicable
TREATMENT SEEKING BEHAVIOUR, COMPLIANCE TOTREATMENT AND SELF REPORTED RISK FOR MALARIAAMONG MALARIA AFFECTED INDIVIDUALSCTRI/2013/06/003715JAIJO K JOSE100
Active, not recruiting
Not Applicable
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyGrass pollen induced rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisEUCTR2009-014522-41-ATALK-Abelló A/S100
Active, not recruiting
Not Applicable
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyEUCTR2009-014522-41-DEALK-Abelló A/S100
Active, not recruiting
Not Applicable
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyGrass pollen induced rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisEUCTR2009-014522-41-DKALK-Abelló A/S100
Recruiting
Not Applicable
on-interventional Study to analyse the tolerability and effectiveness of a chemotherapy with taxanes (Eurotere® / Eurotaxel®) on an everyday basis to treat breast cancerC50.9Breast, unspecifiedDRKS00004212apharm GmbH & Co.KG750